HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica.
Saved in:
| Title: | HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica. |
|---|---|
| Authors: | Awada B; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., Hamie M; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., El Hajj R; Department of Biological Sciences, Beirut Arab University, Beirut, Lebanon., Derbaj G; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., Najm R; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Makhoul P; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., Ali DH; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon., Abou Fayad AG; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., El Hajj H; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Oct 10; Vol. 13, pp. 1023114. Date of Electronic Publication: 2022 Oct 10 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
